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A B S T R A C T
Background
It is unclear how dysphagic patients should be fed and treated after acute stroke.
Objectives
The objective of this review was to assess the effect of different management strategies for dysphagic stroke patients, in particular how
and when to feed, whether to supplement nutritional intake, and how and whether to treat dysphagia.
Search strategy
We searched the Cochrane Stroke Group trials register, Medline, Embase, ISI, and existing review articles. We contacted researchers in
the field and equipment manufacturers. Date of the most recent searches: March 1999.
Selection criteria
Unconfounded truly or quasi randomised controlled trials in dysphagic patients with acute/subacute (within 3 months) stroke.
Data collection and analysis
Three reviewers independently applied the trial inclusion criteria. Two reviewers assessed trial quality and extracted the data.
Main results
Percutaneous endoscopic gastrostomy (PEG) versus nasogastric tube (NGT) feeding: two trials (49 patients) suggest that PEG reduces
end-of-trial case fatality (Peto Odds Ratio, OR 0.28, 95% CI 0.09 to 0.89) and treatment failures (OR 0.10, 95% CI 0.02 to 0.52),
and improves nutritional status, assessed as weight (Weighted Men Difference, WMD +4.1 kg, 95% CI -4.3 to +12.5), mid-arm
circumference (WMD +2.2 cm, 95% CI -0.5 to +4.9) or serum albumin (WMD + 7.0 g/l, 95% CI +4.9 to +9.1) as compared with
NGT feeding; two larger studies are ongoing. Timing of feeding: no completed trials; one large study is ongoing. Swallowing therapy
for dysphagia: two trials (85 patients) suggest that formal swallowing therapy does not significantly reduce end-of-trial dysphagia rates
(OR 0.55, 95% CI 0.18 to 1.66). Drug therapy for dysphagia: one trial (17 patients); nifedipine did not alter end-of-trial case fatality or
the frequency of dysphagia. Nutritional supplementation: one trial (42 patients) found a non-significant trend to a lower case fatality,
and significantly increased energy and protein intake; one large trial is ongoing and data is awaited from two other studies. Fluid
supplementation: one trial (20 patients) found that supplementation did not alter the time to resolution of dysphagia.
Authors’ conclusions
Too few studies have been performed, and these have involved too few patients. PEG feeding may improve outcome and nutrition as
compared with NGT feeding. Further research is required to assess how and when patients are fed, and the effect of swallowing or drug
therapy on dysphagia.
P L A I N L A N G U A G E S U M M A R Y
Strategies to feed and treat people with swallowing difficulties after a stroke (dysphagia)
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Difficulties in swallowing occur in up to half of people experiencing a non-fatal stroke. Although some spontaneously recover this
function in the first two weeks, many continue to have problems that interfere with physical function, nutrition, recovery and quality
of life. Because of the inability to swallow safely, fluid can also get into the airways causing chest infections and pneumonia. People can
be fed through a tube, inserted either up the nose and into the stomach (nasogastric tube) or through the skin of the abdomen into the
stomach (percutaneous endoscopic gastrostomy). Nasogastric tubes are easy to insert but many people find them uncomfortable and
pull them out. Two controlled trials (49 patients) looked at the effectiveness of the two types of feeding tubes. The tube through the
abdomen was associated with fewer deaths and treatment failures. This tube does require an operation and may be associated with chest
infections and infection around the insertion site but does not irritate the patient. From two trials (85 patients), formal swallowing
therapy did not significantly reduce dysphagia compared with standard treatment and in 17 patients the drug nifedipine was ineffective.
B A C K G R O U N D
Dysphagia is common after stroke involving between 27% and
50% of patients (Gordon 1987; Wolfe 1993; Odderson 1995).
About one half of dysphagic patients either die or recover sponta-
neously within the first 14 days of stroke onset leaving half with
swallowing deficits that can significantly impair function, recov-
ery and quality of life (Barer 1989). Complications of dyspha-
gia include aspiration leading to chest infection and pneumonia
(Brin 1988; Smithard 1996; Teasell 1996; Daniels 1998), malnu-
trition, increased length of hospital stay and re-admission to hospi-
tal (Smithard 1993; Odderson 1995; Smithard 1996). As a result,
dysphagia is associated with an increased risk of death (Smithard
1996). Nutritional deficits are known to be prevalent in stroke pa-
tients at the time of admission and during their hospital stay (Ax-
elsson 1989; Gariballa 1998a). Malnutrition is associated with an
increased mortality and may impair recovery and increase length
of hospital stay thereby increasing costs (Smithard 1993; Gariballa
1998a). Thus, both dysphagia and malnutrition are risk factors
for poor outcome after stroke. Techniques for treating dysphagia,
generally administered by Speech and Language Therapists (SLT),
have been described involving either ’direct’ or ’indirect’ strategies
(Logemann 1993).Direct techniques includemodification of food
consistency (Logemann 1991). Indirect strategies include stimula-
tion of oral and pharyngeal structures (Lazarra 1986). However, it
remains unclear whether patients managed using such techniques
fare better than those receiving no specific dysphagia therapy.Dys-
phagic stroke patients may be fed intravenously (parenteral nutri-
tion) or enterally, the latter via either a nasogastric tube (NGT)
or percutaneous endoscopic gastrostomy (PEG) feeding tube. In-
sertion of a NGT is easy, quick, relatively non-invasive, requires
little training, and has a negligible mortality (O’Mahony 1995);
however, many patients find NGTs uncomfortable and repeatedly
pull the tube out resulting in interrupted feeding and the poten-
tial for malnutrition. In contrast, PEG requires an invasive proce-
dure with insertion of the feeding tube through the anterior ab-
dominal wall, an operation which can be complicated by bleed-
ing, peritonitis or perforation of other abdominal organs. PEG
may be associated with chest infections, local infection around
the insertion site, and tubes being pulled out (Wanklyn 1995).
However, PEG is less irritating and more cosmetically acceptable
to patients; PEG also appears to lead to superior feeding in re-
spect of weight maintenance and nutritional status, at least in pa-
tients with long-term neurogenic dysphagia, e.g. persistent vegeta-
tive state and traumatic brain damage (Wicks 1992). The relative
merits of PEG and NGT, and when to commence feeding, have
been assessed in a qualitative review (O’Mahony 1995). However,
it remains unclear whether, firstly, PEG is superior to NGT feed-
ing in patients with dysphagia secondary to stroke, and secondly,
when feeding should be commenced following stroke onset. In-
travenously feeding of dysphagic patients is generally unnecessary
in view of its cost, invasive nature and risk of infection, except in
patients with enteral dysfunction. This Cochrane systematic re-
view assessed randomised controlled trials, in acute stroke, of (i)
therapy for dysphagia, and (ii) feeding strategies including NGT
and PEG, and timing.
O B J E C T I V E S
To determine, separately in dysphagic and non-dysphagic stroke
patients: i) how and when to feed; ii) what, and how much, food
and fluids to administer; iii) whether therapy improves swallowing
and clinical outcome.
C R I T E R I A F O R C O N S I D E R I N G
S T U D I E S F O R T H I S R E V I E W
Types of studies
All unconfounded truly or quasi randomised controlled trials in-
volving patients with acute stroke and comparing:
In dysphagic patients:
i) formal swallowing assessment versus no (or limited) assessment,
or
ii) formal swallowing treatment versus no (or limited) treatment
(just assessment), or
iii) early feeding versus late feeding, or
iv) parenteral versus enteral feeding, or
v) PEG versus NGT feeding, or
2Interventions for dysphagia in acute stroke (Review)
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd
vi) types of fluids.
In non-dysphagic subjects:
i) nutritional supplementation versus no supplementation.
Trials were excluded if they recruited patients after three months
of stroke onset or if they involved a large proportion of patients
with non-stroke causes of dysphagia.
Types of participants
Patients with acute stroke whether of ischaemic or haemorrhagic
type.Dysphagia had to be diagnosed either clinically or using vide-
ofluoroscopy. Trials assessing nutritional supplementation could
include dysphagic or non-dysphagic patients.
Types of intervention
Four main types of intervention were analysed:
i) the effect of feeding route, including PEG, NGT, intravenous
and subcutaneous; or
ii) the timing of feeding; or
iii) the effect of nutritional and fluid supplementation; or
iv) the effect of formal swallowing therapy.
Types of outcome measures
Information on the following outcome measures was obtained for
each trial, where available:
i) case fatality at end of trial;
ii) deterioration (within 4 weeks) - judged using a stroke neuro-
logical impairment scale;
iii) late disability - assessed using an ADL scale;
iv) resumption of normal feeding - judged as oral intake of normal
quality food;
v) length of hospital stay;
vi) discharge destination;
vii) quality of life;
viii) frequency of aspiration;
ix) nutritional measures, e.g. weight, arm circumference, serum
albumin;
x) pneumonia - determined clinically or radiographically;
xi) feeding tube failures;
xii) resolution of dysphagia, i.e. resumption of normal feeding.
S E A R C H M E T H O D S F O R
I D E N T I F I C A T I O N O F S T U D I E S
See: Cochrane Stroke Group methods used in reviews.
This review has drawn on the search strategy developed for
the Stroke Group as a whole. All possible relevant trials were
identified in the Specialised Register of Controlled Trials (see
review group details for more information). The register was
last searched by the Stroke Group Co-ordinator for this review
in March 1999 using a search strategy designed to identify all
relevant trials. We also contacted the Special Interest Group
in Adult Acquired Dysphagia of the Royal College of Speech
and Language Therapists, and companies who manufacture
PEG/NGT related equipment to see if they had information on
ongoing trials of dysphagia treatment or feeding route.
M E T H O D S O F T H E R E V I E W
Three of us independently selected trials for inclusion in the
review and extracted data from the trial reports. We then sought
additional information from the principal investigators of the
trials that appeared to meet the inclusion criteria. We noted
information on randomisation, blinding, analysis, the number
of patients randomised, time of treatment from stroke, type of
dysphagia therapy, patient withdrawals and losses to follow-up,
and relevant outcomes (defined above).We tested for heterogeneity
and calculated a weighted estimate of the typical treatment effect
across trials using the odds ratio (OR) for binary data andweighted
mean difference (WMD) for continuous data using the Cochrane
statistical package, “Review Manager” (Revman 3.1 for Mac). We
performed sensitivity analyses relating tomethodof randomisation
(true versus quasi), outcome blinding, stroke type (infarct versus
haemorrhage), and time to treatment.
D E S C R I P T I O N O F S T U D I E S
PEG versus NGT feeding
Four trials comparing PEG and NGT feeding were identified
(Baeten 1992; Park 1992; Norton 1996; Bath 1997) of which two
were excluded because most patients did not have dysphagia sec-
ondary to stroke (Baeten 1992; Park 1992). Norton and colleagues
studied 30 patients at 2 centres (Norton 1996). The unpublished
study of Bath et al was a factorial trial of PEG versus NGT and
formal swallowing therapy versus conservative swallowing man-
agement (Bath 1997). This trial planned to enrol 160 patients but
ceased early because of the high study case fatality rate (58%).
The studies of Norton et al and Bath et al recruited a total of 49
patients (Norton 1996; Bath 1997). Two other trials are ongoing:
FOOD and PEGASUS (FOOD; PEGASUS).
Timing of feeding
No completed RCTs assessing this question were found. One trial
is ongoing (FOOD). A study assessing the effect of early versus
later enteral feeding onhospital length of staywas excludedbecause
it was not randomised (Nyswonger 1992).
Swallowing therapy for dysphagia
Four trials assessing the effect of swallowing therapy were found
(Rosenbek 1991; DePippo 1994; Sukthankar 1994; Mann 1997).
Three of these were excluded for reasons of (i) crossover design
(Rosenbek 1991), (ii) no control group (DePippo 1994), and (iii)
mixed aetiology of dysphagia (Sukthankar 1994). The study of
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Mann is assessing the effect of graded amounts of swallowing ther-
apy in 300 patients; interim results were published on 99 patients
(Mann 1997).
Drug therapy for dysphagia
Only one study was identified which involved administration of
nifedipine (a dihydropyridine calcium channel blocker) to 17 pa-
tients (Perez 1997).
Nutritional supplementation
Four studies were found which assessed the effect of calorie sup-
plementation. One study assessed non-dysphagic patients with
impaired nutritional status (Gariballa 1998). Correspondence is
awaited from two sets of authors (Honda 1990; Davalos 1994)
while one trial is ongoing (FOOD).
Fluid supplementation
One study was found which compared administering free water
and thickened fluids with thickened fluids alone in patients known
to aspirate thin fluids (Garon 1997).
Miscellaneous studies
Three other studies were identified. The first, a trial compar-
ing hydration routes (intravenous versus subcutaneous) (Challiner
1994), was excluded because no outcomemeasures relevant to this
reviewwere recorded. A second study, assessing the effect of referral
to speech& language therapy (SALT), was excluded because it was
not randomised (Wimbury 1990). The third study assessed palatal
electrical stimulation and was non-randomised (Park 1997).
Definition of patients
Five studies involving “dysphagic” patients gave definitions of dys-
phagia (expanded definitions are present in the relevant publica-
tions):
“... assessment includes cranial nerve and orofacial examinations
and swallow trials on specified consistencies with special reference
to those structures, functions and features significant in swallow-
ing, e.g. voice quality.” (Bath 1997);
“... documented aspiration of thin liquids only, as verified by bar-
ium videofluoroscopic swallow evaluation.” (Garon 1997);
“... clinical and videofluoroscopic evidence of dysphagia ...” (Mann
1997);
“... the absence of a normal gag reflex or the inability to swallow
50 ml of sterile water easily without choking, or both.” (Norton
1996);
“... who required compensatory techniques and a modified diet to
maintain nutrition.” (Perez 1997).
The study of food supplementation did not define impaired nu-
tritional status (Gariballa 1998).
M E T H O D O L O G I C A L Q U A L I T Y
Four trials involved randomisation by computer thereby ensur-
ing concealment of allocation (Bath 1997; Garon 1997; Mann
1997; Perez 1997). Randomisation procedures were unclear in two
studies (Norton 1996; Gariballa 1998). Baseline prognostic fac-
tors were similar in three trials (Garon 1997; Perez 1997; Garib-
alla 1998); matching in the other three studies was unclear (Nor-
ton 1996; Bath 1997; Mann 1997). Outcomes were assessed in a
blinded fashion in two trials (Mann 1997; Perez 1997) and un-
blinded in the other two studies (Norton 1996; Bath 1997); out-
come blinding was unclear in two trials (Garon 1997; Gariballa
1998).
R E S U L T S
No sensitivity analyses were performed.
PEG versus NGT feeding
PEG was associated with significantly lower end-of-trial case fa-
tality rates (odds ratio, OR 0.28, 95% CI 0.09 to 0.89) and treat-
ment failures (OR 0.10, 95% CI 0.02 to 0.52) than NGT feed-
ing in the two trials comparing these (Norton 1996; Bath 1997).
PEG feeding was also associated with improvedmeasures of nutri-
tion, including higher weight (weighted mean difference, WMD
+4.1 kg, 95% CI -4.3 to +12.5), mid-arm circumference (WMD
+2.2 cm, 95% CI -0.5 to +4.9) and serum albumin concentration
(WMD +7.0 g/l, 95% CI +4.9 to +9.1) although only the last
was significant. However, the confidence intervals were wide for
all measures due to the small number of subjects (49) studied.
Timing of feeding
No data available.
Nutritional supplementation
Data only available from one small trial (Gariballa 1998). Nu-
tritional supplementation was associated with a non-significant
trend to a lower case fatality, and significantly increased energy
and protein intake.
Fluid supplementation
Data only available from one small trial (Garon 1997). Fluid sup-
plementation did not alter the time to resolution of dysphagia.
Swallowing therapy for dysphagia
Formal swallowing therapy was associated with a non-significant
reduction in end-of-trial dysphagia (OR 0.55, 95% CI 0.18 to
1.66) as compared with standard care in the two trials comparing
these (Bath 1997; Mann 1997).
Drug therapy for dysphagia
Data only available from one small trial (Perez 1997). Drug ther-
apy with nifedipine did not alter end-of-trial case fatality or the
frequency of dysphagia.
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D I S C U S S I O N
Only six studies, all small, were identified which assessed feeding
and swallowing treatment strategies in stroke patients. Five of these
studies involved patients with dysphagia; one trial studied non-
dysphagic patients. It has been proposed that other RCTs may
have been performed but never published with the results now lost
in “file drawers” (Koretz 1996).
Limited evidence from two trials suggests that PEG feedingmay be
associated with a better outcome and nutrition than NGT feeding
(Kearns 1996). However, no data are available on when feeding
should be commenced or whether nutritional intake should be
supplemented.
The large ongoing FOOD trial should add considerably to knowl-
edge on the timing and route of feeding in dysphagic stroke pa-
tients. This study is also addressing whether oral supplemental
feeding benefits non-dysphagic stroke patients, a question ad-
dressed in one existing small trial. One small trial assessed the ef-
fect of giving water to patients who aspirate thin fluid.
Only two trials have assessed the effect of formal swallowing ther-
apy on resolution of dysphagia and no reliable conclusions can be
drawn.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Too few studies have been performed and patients included to
allowdefinitive statements to bemade onmanagement and feeding
strategies for dysphagic stroke patients.
Implications for research
It is evident that very few RCTs have examined the management
of feeding in stroke patients and the treatment of dysphagia. The
questions of (i) whether PEG is superior to NGT feeding, (ii)
whether supplemental feeding is beneficial, and (iii) when feeding
should commence, are now being tested in two trials (FOOD,
PEGASUS). However, whether swallowing or drug therapy im-
prove dysphagia remains unclear and further research needs to be
initiated.
F E E D B A C K
Length of stay
Summary
The graph in Metaview for ’length of stay in hospital’ in the com-
parison of feeding routes does not have any data in it.
Author’s reply
’Length of stay in hospital’ was a pre-planned outcome measure.
Unfortunately, no data was available from any of the included
trials. Hence, this comparison should have been removed from
Metaview, and will be in the next version of the review unless new
data become available.
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T A B L E S
Characteristics of included studies
Study Bath 1997
Methods Computer-generated randomisation by minimisation (Medistat software). Outcomes assessed unblinded.
Analysis by ITT. Crossovers: 3 NGT to PEG, 0 PEG to NGT. Balancing of baseline prognostic factors
between treatment groups unclear.
Participants 1 centre inUK. 19patients: 8male, 11 female;mean age 77 (SD11) years. 13 ischaemic stroke, 6 haemorrhagic
stroke; 100% CT. Enrollment within 2 weeks of stroke onset.
Interventions Factorial trial: PEG versus NGT; intensive versus conservative swallowing therapyPEG:NGT: up to 3 NG
tubes.Intensive swallowing therapy: as for conservative, plus voluntary control (tongue-holding), sensory
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Characteristics of included studies (Continued )
stimulation (tactile, oromotor exercises, swallow practice).Conservative swallowing therapy: review, advice
regarding feeding route, postural/dietary modification, safe swallowing methods.
Outcomes Primary outcomes: Resumption of safe feeding at 12 weeks, weight loss < 5% at 6 weeks, discharge by 6
weeks.Secondary outcomes: impairment, disability, handicap, quality of life, tube failures, chest infection,
oropharngeal delay time (by videofluroscopy) at 4 weeks.
Notes Exclusions: orogastrointestinal disease, concurrent severe illness, coagulopathy, pre-morbid dependency, sever
dementia, psychiatric illness.Follow-up: 3 months.
Allocation concealment A – Adequate
Study Gariballa 1998
Methods Method of randomisation unclear. Blinding of outcomes unclear. Analysis by ITTunclear. Crossovers unclear.
Baseline factors balanced.
Participants 1 centre in UK. 42 non-dysphagic patients with impaired nutritional status: gender ratio and mean age
unclear. All ischaemic stroke. Enrollment within 1 week of stroke onset.
Interventions Rx: daily enteral sip feeding and usual hospital food.C: usual hospital food.Treatment for 4 weeks.
Outcomes Primary outcomes: energy intake and nutritional status.Secondary outcomes: 3 month case fatality.
Notes Exclusions: dysphagia, normal nutritional status, haemorrhagic stroke.Follow-up: 3 months.
Allocation concealment B – Unclear
Study Garon 1997
Methods Computer-generated randomisation. Outcomes assessed unblinded. Analysis by ITT. No crossovers, exclu-
sions post-randomisation, or losses to follow-up. Baseline prognostic factors balanced between treatment
groups.
Participants 1 centre in USA. 20 patients with documented aspiration of thin fluids only: 14 male, 6 female; mean age
76.8 years. Stroke types unclear. Enrollment within 3 weeks of stroke onset: mean 12.8 days, range 4-19
days.
Interventions Rx: thickened fluids and free water.C: thickened fluids only.Treatment until aspiration resolved (7-64 days).
Outcomes Outcomes: development of pneumonia, dehydration, and satisfaction.Time to resolution of aspiration to
thin fluids.
Notes Exclusions: aspiration to thickened fluids.Follow-up: 30 days beyond resolution of aspiration.
Allocation concealment A – Adequate
Study Mann 1997
Methods Computer-generated randomisation. Blinded outcome assessments by SALT. Analysis by ITT unclear. Bal-
ancing of baseline prognostic factors between treatment groups unclear.
Participants 1 centre in Australia. 99 patients, gender ratio unclear, mean age 73 years. Stroke types unclear. Enrollment
within 2 weeks of stroke onset: mean 2 days, range 0-12 days.
Interventions Rx 1: standardised high intensity swallowing therapy;Rx 2: standardised low intensity swallowing therapy;C:
usual care.Treatment for up to 1 month.
Outcomes Outcomes: time to return to normal diet; aspiration pneumonia.
Notes Trial continues to 300 patients. Interim results published at 99 patients.Follow-up: 6 months.
Allocation concealment A – Adequate
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Study Norton 1996
Methods Method of randomisation unclear, code in sealed envelopes. Outcome assessments unblinded. Analysis by
ITT. No crossovers, exclusions post-randomisation, or losses to follow-up. Balancing of baseline prognostic
factors for treatment groups unclear.
Participants 2 centres in UK. 30 subjects: 11 male, 19 female; mean age 77. Stroke types not given; CT performed in
25 patients. Enrollment 14 (+/- 3) days post-admission. All patients were unconscious at admission with a
dense hemiplegia. Dysphagia assessed by absence of normal gag reflex or inability to swallow 50 ml of sterile
water without choking.
Interventions PEG tube (12 French gauge Fresenius or 24 French gauge Wilson Cook) inserted using percutaneous ap-
proach with pull-through. Antibiotic (cefuroxine 750mg iv) given prophylactically; sedation with 5-10mg
diazepam.NGT (Flocare 500).All patients got standard enteral feed (Nutrison). Feed delivered via Flowcare
500 at 50ml/h for first 24 hours increased to 100ml/hour. Patients fed in a semi-recumberant position for 6
weeks.
Outcomes Case fatality at 6 weeks. Amount of feed administered. Change in nutritional status. Treatment failure.
Length of hospital stay. Number of times tube inserted.
Notes Exclusions: previous history of gastrointestinal disease, unfit for endoscopy or iv sedation.Follow-up: 6 weeks.
Allocation concealment B – Unclear
Study Perez 1997
Methods Computer-generated randomisation. Triple-blind trial; outcomes assessed by blinded therapist. Analysis by
ITT. No crossovers or losses to follow-up. One subject withdrawn with heart failure (nifedipine group).
Baseline prognostic factors balanced between treatment groups.
Participants 1 UK centre. 17 patients; nifedipine: 4 male, 4 female, mean age 77 (SD 7); placebo: 4 male, 5 female, mean
age 77 (SD 6). All first ischaemic stroke, 100% CT. Enrollment 2 weeks after stroke.
Interventions Rx: nifedipine (LA 30 mg orally daily, Bayer UK).Pl: matching tablet.Treatment for 4 weeks.
Outcomes Primary outcome: clinical improvement in swallowing.Other outcomes: incidence of silent aspiration, pha-
ryngeal transit time and response duration, swallowing delay (all assessed by videofluoroscopy), death.
Notes Exclusions: unable to sit, high clinical risk of aspiration, receptive dysphasia, cognitive impairment, pre-stroke
dysphagia, existing neurological or psychiatric disease, current treatment with calcium channel blockers or
aminophylline.Follow-up: 4 weeks.1 patient withdrawn with heart failure.
Allocation concealment A – Adequate
C, control group; CT, computer tomography; ITT, intention to treat analysis; NGT, nasogastric tube; OR, odds ratio; PEG, percutaneous endoscopic
gastrostomy tube; Pl, placebo group; Rx, treatment group; SALT, speech & language therapist (speech pathologist); SD, standard deviation; WMD,
weighted mean difference.
Characteristics of excluded studies
Study Reason for exclusion
Baeten 1992 RCT comparing PEG and NGT feeding in 90 dysphagic patients with neurological problems (N=42, 47%), ear
nose and throat disease (N=39, 43%) or post-surgery (N=9, 10%).Study excluded because most patients did not
have stroke-related dysphagia.
Challiner 1994 RCT comparing hydration routes in 34 elderly acute stroke patients with either impaired consciousness or dyspha-
gia:Group 1: subcutaneous hydration, N=17;Group 2: intravenous hydration, N=17.2 litres of dextrose-saline/day
given for 3 days. No difference in serum osmolality; subcutaneous hydration cheaper.Study excluded because out-
come measures (plasma osmolality and sodium, and treatment cost) not relevant to this review.
DePippo 1994 RCT comparing three active interventions in 115 dysphagic stroke patients taught compensatory swallowing
techniques:Group 1: patient/family choice of diet and food consistency, N=38;Group 2: therapist prescribed diet
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Characteristics of excluded studies (Continued )
and food consistency, N=38;Group 3: therapist prescribed diet and food consistency, with daily reinforcement of
compensatory swallowing techniques, N=39.Study excluded because no control group.
Nyswonger 1992 Retrospective case control study in 52 dysphagia stroke patients comparing those who were fed, or not, within 72
hours of admission. Length of stay was shorter in those fed early, 20.1 days versus 29.8 days.Study excluded because
not RCT.
Park 1992 RCT comparing PEG and NGT feeding in 40 dysphagic patients.Study excluded because:(i) only 18 patients
(45%) had cerebrovascular disease;(ii) only 5 of these were enrolled within 2 months of stroke onset;(iii) individual
patient data unavailable so not possible to analyse subgroup of appropriate patients.
Park 1997 Single case study of oral (palatal) electrical stimulation in 4 stroke patients with chronic dysphagia.Study excluded
because:(i) non RCT;(ii) non acute patients.
Rosenbek 1991 Crossover trial of thermal stimulation in 7 male dysphagic patients with multiple previous strokes.Study excluded
because:(i) crossover trial;(ii) only 2 of 7 patients recruited within 3 months of stroke onset;(iii) randomisation
status unclear.
Sukthankar 1994 RCT comparing swallowing therapy in 9 patients with dysphagia secondary to stroke or head injury:Group 1:
regular therapy, N=4;Group 2: regular therapy and oral exercises, N=2;Group 3: regular therapy and oral exercises
with visual and audio biofeedback, N=3.Study excluded because:(i) dysphagia of mixed aetiology;(ii) outcome
measures (tongue and lip motor force) not relevant to this review.
Wimbury 1990 Non-randomised comparisonof speech& language therapy (SALT) referrals for assessment of speech and swallowing
in elderly patients, 40% of whom had had a stroke.Group 1: 2 wards who filled in a questionaire relating to
speech and swallowing problems in 162 admissions;Group 2: 2 wards who did not fill in a questionaire in 233
admissions.Study excluded because:(i) not randomised;(ii) most patients not stroke.
NGT, nasogastric tube; PEG, percutaneous endoscopic gastrostomy; RCT, randomised controlled trial.
Characteristics of ongoing studies
Study FOOD
Trial name or title FOOD (Feed or ordinary Diet). Part of the International Stroke Trials Collaboration
Participants Acute stroke < 1 week
Size: 9000
(a) 6000
(b) 2000
(c) 1000
Interventions (a) oral supplemental feeding
(b) early versus late tube feeding
(c) PEG tube versus NG tube feeding
Outcomes Primary:
(a) dependence (modified Rankin score >=3)
(b,c) severe dependence (modified Rankin score >=4)
Secondary outcomes:
case fatality at 1 and 6 months, length of stay in hospital, number of days of tube feeding, adverse effects of
feeding regimes, premature cessation of feeding regimes, quality of life
Starting date 1996
Contact information Dr M Dennis
FOODTrial Co-ordinatingCentre,NeurosciencesTrialsUnit, Dept ofClinicalNeurosciences,WesternGeneral
Hospital, Edinburgh EH42XU.Tel: +44 131 537 3126; Fax: +44 131 332 5150; email: msd@skull.dcn.ed.ac.uk
Notes Funding:
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NHS R&D HTA (UK); Stroke Association (UK); Chief Scientist Office, Scottish Executive; Chest Heart and
Stroke Scotland (UK)
Study PEGASUS
Trial name or title Percutaneous Endoscopic Gastrostomy After Stroke
Participants Dysphagia at 5-7 days post stroke
Size: 400
Interventions PEG versus conservative (limited oral, NGT, IV) feeding for 15 days, then best medical treatment
Outcomes Primary outcomes:
Oxford Handicap Score at 6 months
Secondary outcomes:
mortality, chest infection, nutritional status, length of stay, discharge disposition
Starting date 1995
Contact information
Notes
A N A L Y S E S
Comparison 01. Feeding route
Outcome title
No. of
studies
No. of
participants Statistical method Effect size
01 Case fatality at end of trial 2 49 Peto Odds Ratio 95% CI 0.28 [0.09, 0.89]
02 Death or disabled at end of trial 1 19 Peto Odds Ratio 95% CI Not estimable
03 Feeding tube in situ at end of
trial
1 7 Peto Odds Ratio 95% CI 0.17 [0.00, 9.12]
04 Weight at end of trial (LVCF) 2 34 Weighted Mean Difference (Fixed) 95% CI 4.08 [-4.32, 12.48]
05 Mid-arm circumference
(LVCF)
2 35 Weighted Mean Difference (Fixed) 95% CI 2.20 [-0.48, 4.89]
06 Albumin (LVCF) 2 40 Weighted Mean Difference (Fixed) 95% CI 7.00 [4.86, 9.14]
07 Treatment failure 2 49 Peto Odds Ratio 95% CI 0.10 [0.02, 0.52]
08 Missed feed (at least one day) 1 30 Peto Odds Ratio 95% CI 0.04 [0.01, 0.20]
09 Length of stay in hospital 0 0 Weighted Mean Difference (Fixed) 95% CI Not estimable
Comparison 02. Swallowing therapy
Outcome title
No. of
studies
No. of
participants Statistical method Effect size
01 Case fatality at end of trial 2 36 Peto Odds Ratio 95% CI 1.07 [0.23, 5.04]
02 Dysphagia at end of trial 3 102 Peto Odds Ratio 95% CI 0.55 [0.18, 1.66]
03 Pharyngeal transit time
(seconds)
0 0 Weighted Mean Difference (Fixed) 95% CI Not estimable
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Comparison 03. Fluid supplementation
Outcome title
No. of
studies
No. of
participants Statistical method Effect size
01 Time to resolution of dysphagia
(days)
1 20 Weighted Mean Difference (Fixed) 95% CI -8.10 [-20.84, 4.64]
Comparison 04. Food supplementation
Outcome title
No. of
studies
No. of
participants Statistical method Effect size
01 Case fatality at end of trial 1 42 Peto Odds Ratio 95% CI 0.25 [0.06, 1.08]
02 Energy intake (kcal/day) 1 42 Weighted Mean Difference (Fixed) 95% CI 723.00 [522.95,
923.05]
03 Protein intake (g/day) 1 42 Weighted Mean Difference (Fixed) 95% CI 21.00 [12.95, 29.05]
I N D E X T E R M S
Medical Subject Headings (MeSH)
Deglutition Disorders [∗etiology; ∗rehabilitation]; ∗Enteral Nutrition; Gastrostomy; Intubation, Gastrointestinal; Stroke
[∗complications; ∗rehabilitation]
MeSH check words
Humans
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G R A P H S A N D O T H E R T A B L E S
Analysis 01.01. Comparison 01 Feeding route, Outcome 01 Case fatality at end of trial
Review: Interventions for dysphagia in acute stroke
Comparison: 01 Feeding route
Outcome: 01 Case fatality at end of trial
Study Treatment Control Peto Odds Ratio Weight Peto Odds Ratio
n/N n/N 95% CI (%) 95% CI
01 PEG versus NGT
Norton 1996 2/16 8/14 59.6 0.14 [ 0.03, 0.64 ]
Bath 1997 6/10 6/9 40.4 0.76 [ 0.12, 4.69 ]
Total (95% CI) 26 23 100.0 0.28 [ 0.09, 0.89 ]
Total events: 8 (Treatment), 14 (Control)
Test for heterogeneity chi-square=1.94 df=1 p=0.16 I² =48.3%
Test for overall effect z=2.15 p=0.03
0.1 0.2 0.5 1 2 5 10
PEG better NGT better
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Analysis 01.02. Comparison 01 Feeding route, Outcome 02 Death or disabled at end of trial
Review: Interventions for dysphagia in acute stroke
Comparison: 01 Feeding route
Outcome: 02 Death or disabled at end of trial
Study Treatment Control Peto Odds Ratio Weight Peto Odds Ratio
n/N n/N 95% CI (%) 95% CI
01 PEG versus NGT
Bath 1997 10/10 9/9 0.0 Not estimable
Total (95% CI) 10 9 0.0 Not estimable
Total events: 10 (Treatment), 9 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
0.1 0.2 0.5 1 2 5 10
PEG better NGT better
Analysis 01.03. Comparison 01 Feeding route, Outcome 03 Feeding tube in situ at end of trial
Review: Interventions for dysphagia in acute stroke
Comparison: 01 Feeding route
Outcome: 03 Feeding tube in situ at end of trial
Study Treatment Control Peto Odds Ratio Weight Peto Odds Ratio
n/N n/N 95% CI (%) 95% CI
01 PEG versus NGT
Bath 1997 3/4 3/3 100.0 0.17 [ 0.00, 9.12 ]
Total (95% CI) 4 3 100.0 0.17 [ 0.00, 9.12 ]
Total events: 3 (Treatment), 3 (Control)
Test for heterogeneity: not applicable
Test for overall effect z=0.87 p=0.4
0.1 0.2 0.5 1 2 5 10
PEG better NGT better
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Analysis 01.04. Comparison 01 Feeding route, Outcome 04 Weight at end of trial (LVCF)
Review: Interventions for dysphagia in acute stroke
Comparison: 01 Feeding route
Outcome: 04 Weight at end of trial (LVCF)
Study Treatment Control Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
01 PEG versus NGT
Norton 1996 13 61.00 (11.00) 8 57.80 (10.00) 84.3 3.20 [ -5.95, 12.35 ]
Bath 1997 6 59.80 (24.20) 7 51.00 (11.60) 15.7 8.80 [ -12.38, 29.98 ]
Total (95% CI) 19 15 100.0 4.08 [ -4.32, 12.48 ]
Test for heterogeneity chi-square=0.23 df=1 p=0.63 I² =0.0%
Test for overall effect z=0.95 p=0.3
-10 -5 0 5 10
NGT better PEG better
Analysis 01.05. Comparison 01 Feeding route, Outcome 05 Mid-arm circumference (LVCF)
Review: Interventions for dysphagia in acute stroke
Comparison: 01 Feeding route
Outcome: 05 Mid-arm circumference (LVCF)
Study Treatment Control Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
01 PEG versus NGT
Norton 1996 13 26.30 (5.30) 8 23.80 (1.80) 73.0 2.50 [ -0.64, 5.64 ]
Bath 1997 7 27.00 (6.20) 7 25.60 (3.20) 27.0 1.40 [ -3.77, 6.57 ]
Total (95% CI) 20 15 100.0 2.20 [ -0.48, 4.89 ]
Test for heterogeneity chi-square=0.13 df=1 p=0.72 I² =0.0%
Test for overall effect z=1.61 p=0.1
-10 -5 0 5 10
NGT better PEG better
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Analysis 01.06. Comparison 01 Feeding route, Outcome 06 Albumin (LVCF)
Review: Interventions for dysphagia in acute stroke
Comparison: 01 Feeding route
Outcome: 06 Albumin (LVCF)
Study Treatment Control Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
01 PEG versus NGT
Norton 1996 15 30.10 (3.60) 10 22.30 (2.20) 88.4 7.80 [ 5.52, 10.08 ]
Bath 1997 7 27.90 (6.10) 8 27.00 (6.30) 11.6 0.90 [ -5.38, 7.18 ]
Total (95% CI) 22 18 100.0 7.00 [ 4.86, 9.14 ]
Test for heterogeneity chi-square=4.10 df=1 p=0.04 I² =75.6%
Test for overall effect z=6.41 p<0.00001
-10 -5 0 5 10
NGT better PEG better
Analysis 01.07. Comparison 01 Feeding route, Outcome 07 Treatment failure
Review: Interventions for dysphagia in acute stroke
Comparison: 01 Feeding route
Outcome: 07 Treatment failure
Study Treatment Control Peto Odds Ratio Weight Peto Odds Ratio
n/N n/N 95% CI (%) 95% CI
01 PEG versus NGT
Norton 1996 0/16 3/14 51.1 0.10 [ 0.01, 1.05 ]
Bath 1997 0/10 3/9 48.9 0.09 [ 0.01, 1.03 ]
Total (95% CI) 26 23 100.0 0.10 [ 0.02, 0.52 ]
Total events: 0 (Treatment), 6 (Control)
Test for heterogeneity chi-square=0.00 df=1 p=0.97 I² =0.0%
Test for overall effect z=2.73 p=0.006
0.1 0.2 0.5 1 2 5 10
PEG better NGT better
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Analysis 01.08. Comparison 01 Feeding route, Outcome 08 Missed feed (at least one day)
Review: Interventions for dysphagia in acute stroke
Comparison: 01 Feeding route
Outcome: 08 Missed feed (at least one day)
Study Treatment Control Peto Odds Ratio Weight Peto Odds Ratio
n/N n/N 95% CI (%) 95% CI
01 PEG versus NGT
Norton 1996 0/16 10/14 100.0 0.04 [ 0.01, 0.20 ]
Total (95% CI) 16 14 100.0 0.04 [ 0.01, 0.20 ]
Total events: 0 (Treatment), 10 (Control)
Test for heterogeneity: not applicable
Test for overall effect z=4.07 p=0.00005
0.1 0.2 0.5 1 2 5 10
PEG better NGT better
Analysis 01.09. Comparison 01 Feeding route, Outcome 09 Length of stay in hospital
Review: Interventions for dysphagia in acute stroke
Comparison: 01 Feeding route
Outcome: 09 Length of stay in hospital
Study Treatment Control Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N
Mean(SD) N
Mean(SD) 95% CI (%) 95% CI
01 PEG versus NGT
Total (95% CI) 0 0 0.0 Not estimable
Test for heterogeneity: not applicable
Test for overall effect: not applicable
-10 -5 0 5 10
PEG better NGT better
17Interventions for dysphagia in acute stroke (Review)
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd
Analysis 02.01. Comparison 02 Swallowing therapy, Outcome 01 Case fatality at end of trial
Review: Interventions for dysphagia in acute stroke
Comparison: 02 Swallowing therapy
Outcome: 01 Case fatality at end of trial
Study Peto Odds Ratio Weight Peto Odds Ratio
n/N n/N 95% CI (%) 95% CI
01 Drug therapy
Perez 1997 1/8 1/9 29.1 1.13 [ 0.06, 19.96 ]
Subtotal (95% CI) 8 9 29.1 1.13 [ 0.06, 19.96 ]
Total events: 1 (), 1 ()
Test for heterogeneity: not applicable
Test for overall effect z=0.09 p=0.9
02 Swallowing therapy
Bath 1997 7/11 5/8 70.9 1.05 [ 0.17, 6.58 ]
Subtotal (95% CI) 11 8 70.9 1.05 [ 0.17, 6.58 ]
Total events: 7 (), 5 ()
Test for heterogeneity: not applicable
Test for overall effect z=0.05 p=1
Total (95% CI) 19 17 100.0 1.07 [ 0.23, 5.04 ]
Total events: 8 (), 6 ()
Test for heterogeneity chi-square=0.00 df=1 p=0.96 I² =0.0%
Test for overall effect z=0.09 p=0.9
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Analysis 02.02. Comparison 02 Swallowing therapy, Outcome 02 Dysphagia at end of trial
Review: Interventions for dysphagia in acute stroke
Comparison: 02 Swallowing therapy
Outcome: 02 Dysphagia at end of trial
Study Peto Odds Ratio Weight Peto Odds Ratio
n/N n/N 95% CI (%) 95% CI
01 Drug therapy
Perez 1997 3/8 5/9 35.3 0.51 [ 0.08, 3.22 ]
Subtotal (95% CI) 8 9 35.3 0.51 [ 0.08, 3.22 ]
Total events: 3 (), 5 ()
Test for heterogeneity: not applicable
Test for overall effect z=0.72 p=0.5
02 Swallowing therapy
Bath 1997 3/4 3/3 7.7 0.17 [ 0.00, 9.12 ]
Mann 1997 51/63 13/15 57.0 0.68 [ 0.16, 2.93 ]
Subtotal (95% CI) 67 18 64.7 0.58 [ 0.15, 2.27 ]
Total events: 54 (), 16 ()
Test for heterogeneity chi-square=0.40 df=1 p=0.53 I² =0.0%
Test for overall effect z=0.78 p=0.4
Total (95% CI) 75 27 100.0 0.55 [ 0.18, 1.66 ]
Total events: 57 (), 21 ()
Test for heterogeneity chi-square=0.42 df=2 p=0.81 I² =0.0%
Test for overall effect z=1.06 p=0.3
0.1 0.2 0.5 1 2 5 10
Therapy better Therapy worse
19Interventions for dysphagia in acute stroke (Review)
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd
Analysis 02.03. Comparison 02 Swallowing therapy, Outcome 03 Pharyngeal transit time (seconds)
Review: Interventions for dysphagia in acute stroke
Comparison: 02 Swallowing therapy
Outcome: 03 Pharyngeal transit time (seconds)
Study Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N
Mean(SD) N
Mean(SD) 95% CI (%) 95% CI
01 Drug therapy
Subtotal (95% CI) 0 0 0.0 Not estimable
Test for heterogeneity: not applicable
Test for overall effect: not applicable
02 Swallowing therapy
Subtotal (95% CI) 0 0 0.0 Not estimable
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 0 0 0.0 Not estimable
Test for heterogeneity: not applicable
Test for overall effect: not applicable
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Analysis 03.01. Comparison 03 Fluid supplementation, Outcome 01 Time to resolution of dysphagia (days)
Review: Interventions for dysphagia in acute stroke
Comparison: 03 Fluid supplementation
Outcome: 01 Time to resolution of dysphagia (days)
Study Treatment Control Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
01 Free thin fluids
Garon 1997 10 19.10 (9.71) 10 27.20 (18.12) 100.0 -8.10 [ -20.84, 4.64 ]
Total (95% CI) 10 10 100.0 -8.10 [ -20.84, 4.64 ]
Test for heterogeneity: not applicable
Test for overall effect z=1.25 p=0.2
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Analysis 04.01. Comparison 04 Food supplementation, Outcome 01 Case fatality at end of trial
Review: Interventions for dysphagia in acute stroke
Comparison: 04 Food supplementation
Outcome: 01 Case fatality at end of trial
Study Treatment Control Peto Odds Ratio Weight Peto Odds Ratio
n/N n/N 95% CI (%) 95% CI
01 Sip feeding
Gariballa 1998 2/21 7/21 100.0 0.25 [ 0.06, 1.08 ]
Total (95% CI) 21 21 100.0 0.25 [ 0.06, 1.08 ]
Total events: 2 (Treatment), 7 (Control)
Test for heterogeneity: not applicable
Test for overall effect z=1.86 p=0.06
0.1 0.2 0.5 1 2 5 10
Favours Treatment Favours Control
Analysis 04.02. Comparison 04 Food supplementation, Outcome 02 Energy intake (kcal/day)
Review: Interventions for dysphagia in acute stroke
Comparison: 04 Food supplementation
Outcome: 02 Energy intake (kcal/day)
Study Treatment Control Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
01 Sip feeding
Gariballa 1998 21 1807.00 (318.00) 21 1084.00 (343.00) 100.0 723.00 [ 522.95, 923.05 ]
Total (95% CI) 21 21 100.0 723.00 [ 522.95, 923.05 ]
Test for heterogeneity: not applicable
Test for overall effect z=7.08 p<0.00001
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Analysis 04.03. Comparison 04 Food supplementation, Outcome 03 Protein intake (g/day)
Review: Interventions for dysphagia in acute stroke
Comparison: 04 Food supplementation
Outcome: 03 Protein intake (g/day)
Study Treatment Control Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
01 Sip feeding
Gariballa 1998 21 65.10 (13.80) 21 44.10 (12.80) 100.0 21.00 [ 12.95, 29.05 ]
Total (95% CI) 21 21 100.0 21.00 [ 12.95, 29.05 ]
Test for heterogeneity: not applicable
Test for overall effect z=5.11 p<0.00001
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